Vitamin D and Type 2 Diabetes - Treat-To-Target

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07448974

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose other
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07448974
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07448974. Randomized; quadruple masking; primary purpose other. Start 2026-08-04 (actual); primary completion 2030-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vitamin D and Type 2 Diabetes - Treat-To-Target
Acronym
D2d-TTT
Condition
Prediabetes
Condition
Type 2 Diabetes (T2DM)
Intervention (Drug)
Vitamin D (Cholecalciferol )
Intervention (Drug)
Placebo
Lead sponsor
Tufts Medical Center (class: other)
Collaborator
Abiogen Pharma (class: industry)

Record details

Record id
cardio:ct-nct07448974
Content hash
2a0b1aea63ccb028036f53b95077f9864eb51eb9a8c94bd2f127d54a09a6a5bd